A Blood Test for Glioblastoma
January 13, 2015 | Terry Sharrer
Using peptide arrays, HealthTell (San Ramon, CA) is testing their product which supposedly offers early, accurate and noninvasive diagnosis of glioblastoma multiforme. The specific peptides are proprietary secrets, but they result in “signatures” that not only identify the presence of a primary brain tumor, but also subclassify it. MORE
Image Credit: HealthTell